Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma
Tuberculosis and Respiratory Diseases - South Korea
doi 10.4046/trd.2011.71.4.286
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
The Korean Academy of Tuberculosis and Respiratory Diseases (KAMJE)